Loading…
XBIT
XBiotech Inc.
NASDAQ· Healthcare· Biotechnology· CUSIP 98400H102
$2.27-1.30%Price as of Aug 29, 18:33 UTC · updated once a day, after the close
Key metrics
- Market cap
- $69.21M
- P/E
- —
- Forward P/E
- 17.5x
- P/B
- 0.5x
- Dividend yield
- —
- Payout
- —
- EPS
- -$1.48
- ROE
- -29.94%
- Profit margin
- 0.00%
- Revenue growth
- —
- Beta
- 0.85
- 52-week high
- $3.44
- 52-week low
- $2.09
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -85.2% over 5Y.
today you would have $167.57▼ -83.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 11 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $2.39 | $3.95 | $4.00 | $3.51 | $11.13 | $15.65 | $18.67 | $5.08 | $3.94 | $10.12 | $10.87 | |
| P/E | — | — | — | — | — | — | — | 1.3x | — | — | — |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MDXHMDxHealth SA | $0.72 | — | — | — | — | $68.77M |
| PLRXPliant Therapeutics Inc | $1.13 | — | 0.5x | — | -50.29% | $69.66M |
| SPROSpero Therapeutics, Inc. | $1.20 | 8.6x | 1.6x | — | 19.17% | $69.88M |
| CSBRChampions Oncology Inc | $4.93 |
About the company
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
- 87
- Austin, United States
Company description provided by Yahoo Finance.